1. Home
  2. APPN vs TARS Comparison

APPN vs TARS Comparison

Compare APPN & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$40.66

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$79.62

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPN
TARS
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
APPN
TARS
Price
$40.66
$79.62
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
$38.40
$73.63
AVG Volume (30 Days)
956.3K
446.7K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$690,755,000.00
$366,100,000.00
Revenue This Year
$15.42
$139.46
Revenue Next Year
$11.07
$49.91
P/E Ratio
N/A
N/A
Revenue Growth
15.96
182.44
52 Week Low
$24.00
$38.51
52 Week High
$46.06
$83.47

Technical Indicators

Market Signals
Indicator
APPN
TARS
Relative Strength Index (RSI) 58.52 63.72
Support Level $39.70 $77.44
Resistance Level $42.76 $83.47
Average True Range (ATR) 1.73 3.59
MACD -0.49 0.14
Stochastic Oscillator 21.64 70.59

Price Performance

Historical Comparison
APPN
TARS

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: